Similar articles

• The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B.

  Walker B, Cullen BM, Kay G, Halliday IM, McGinty A, Nelson J. Walker B, et al. Biochem J. 1992 Apr 15;283 ( Pt 2)(Pt 2):449-53. doi: 10.1042/bj2830449. Biochem J. 1992. PMID: 1575690 Free PMC article.
• An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.

  Falgueyret JP, Black WC, Cromlish W, Desmarais S, Lamontagne S, Mellon C, Riendeau D, Rodan S, Tawa P, Wesolowski G, Bass KE, Venkatraman S, Percival MD. Falgueyret JP, et al. Anal Biochem. 2004 Dec 15;335(2):218-27. doi: 10.1016/j.ab.2004.09.005. Anal Biochem. 2004. PMID: 15556560
• Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length.

  Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R, Kasprzykowski F. Hall A, et al. J Enzyme Inhib. 1992;6(2):113-23. doi: 10.3109/14756369209040742. J Enzyme Inhib. 1992. PMID: 1284427
• Synthesis and properties of Cbz-Phe-Arg-CHN2 (benzyloxycarbonylphenylalanylarginyldiazomethane) as a proteinase inhibitor.

  Zumbrunn A, Stone S, Shaw E. Zumbrunn A, et al. Biochem J. 1988 Mar 1;250(2):621-3. doi: 10.1042/bj2500621. Biochem J. 1988. PMID: 3355540 Free PMC article.
• The current stage of cathepsin B inhibitors as potential anticancer agents.

  Kos J, Mitrović A, Mirković B. Kos J, et al. Future Med Chem. 2014 Jul;6(11):1355-71. doi: 10.4155/fmc.14.73. Future Med Chem. 2014. PMID: 25163003 Review.